股號 / 名稱 | 營業現金流 | 自由現金流 | 淨現金流 |
SYK 史賽克 | 1,528,000,000.0 | 1,383,000,000.0 | 1,111,000,000.0 |
MDT 美敦力 | 2,475,000,000.0 | 2,129,000,000.0 | 312,000,000.0 |
ZBH Zimmer Biomet Holdings Inc | 588,400,000.0 | 446,700,000.0 | 123,600,000.0 |
NVST Envista Holdings Corp | 102,000,000.0 | 93,800,000.0 | 115,800,000.0 |
HCM HUTCHMED (China) Ltd | -7,145,000.0 | -15,398,000.0 | 60,593,000.0 |
ICUI ICU Medical Inc | 91,269,000.0 | 59,297,000.0 | 57,030,000.0 |
BRBR Bellring Brands Inc | 74,200,000.0 | 74,000,000.0 | 36,600,000.0 |
VERU Veru Inc | -6,020,390.0 | -6,020,390.0 | 30,953,570.0 |
EOLS Evolus Inc | 813,000.0 | 452,000.0 | 24,153,000.0 |
OMI Owens & Minor Inc | 111,765,000.0 | 55,440,000.0 | 22,764,000.0 |
APYX Apyx Medical Corp | -2,212,000.0 | -2,305,000.0 | 21,518,000.0 |
BLFS BioLife Solutions Inc | 2,311,000.0 | -73,000.0 | 16,172,000.0 |
CMRX Chimerix Inc | -14,588,000.0 | -14,588,000.0 | 13,543,000.0 |
MGNX MacroGenics Inc | -28,037,000.0 | -28,657,000.0 | 11,058,000.0 |
INMD Inmode Ltd | 61,269,000.0 | 61,248,000.0 | 10,678,000.0 |
XGN Exagen Inc | 8,349,000.0 | 8,243,000.0 | 8,045,000.0 |
CAPR Capricor Therapeutics Inc | -11,594,060.0 | -12,323,280.0 | 5,710,200.0 |
CTSO Cytosorbents Corp | -6,407,410.0 | -6,543,340.0 | 5,568,590.0 |
UTMD Utah Medical Products Inc | 5,332,000.0 | 5,242,000.0 | 4,659,000.0 |
ATRC AtriCure Inc | 4,030,000.0 | 1,244,000.0 | 3,712,000.0 |
ORMP Oramed Pharmaceuticals Inc | -1,418,000.0 | -1,421,000.0 | 3,587,000.0 |
SNES Senestech Inc | -2,019,000.0 | -2,054,000.0 | 3,250,000.0 |
VMD Viemed Healthcare Inc | 13,284,000.0 | 5,352,000.0 | 2,761,000.0 |
ZYXI Zynex Inc | 6,188,000.0 | 5,612,000.0 | 2,062,000.0 |
RMD 瑞思邁 | 272,832,000.0 | 248,274,000.0 | 1,147,000.0 |
UG United-Guardian Inc | 1,127,570.0 | 1,034,190.0 | 1,126,990.0 |
QIPT Quipt Home Medical Corp | 11,734,000.0 | 10,163,000.0 | 1,117,000.0 |
WRBY Warby Parker Inc | 13,665,000.0 | 92,000.0 | 929,000.0 |
LFLY Leafly Holdings Inc | 1,034,000.0 | 731,000.0 | 826,000.0 |
NURO NeuroMetrix Inc | -1,450,500.0 | -1,495,860.0 | 271,400.0 |
NEPH Nephros Inc | -238,000.0 | -313,000.0 | -315,000.0 |
FLGC Flora Growth Corp | -1,131,000.0 | -1,093,000.0 | -413,000.0 |
HUGE FSD Pharma Inc | -851,650.0 | -851,650.0 | -876,870.0 |
ICCC ImmuCell Corp | -723,070.0 | -804,410.0 | -1,010,720.0 |
GHSI Guardion Health Sciences Inc | -1,317,600.0 | -1,317,600.0 | -1,297,660.0 |
GCTK GlucoTrack Inc | -2,411,000.0 | -2,411,000.0 | -2,395,000.0 |
TRIB Trinity Biotech PLC | 242,000.0 | -649,000.0 | -2,570,000.0 |
MRVI Maravai LifeSciences Holdings Inc | 7,790,000.0 | -9,009,000.0 | -4,643,000.0 |
CERS Cerus Corp | -15,183,000.0 | -15,177,000.0 | -5,800,000.0 |
ZVIA Zevia PBC | -6,606,000.0 | -6,673,000.0 | -6,587,000.0 |
PETQ PetIQ Inc | -2,842,000.0 | -5,782,000.0 | -8,245,000.0 |
CLRB Cellectar Biosciences Inc | -9,595,700.0 | -9,862,460.0 | -9,421,450.0 |
PAHC Phibro Animal Health Corp | 31,558,000.0 | 20,599,000.0 | -10,183,000.0 |
SRDX Surmodics Inc | -8,792,000.0 | -9,512,000.0 | -18,064,000.0 |
OMER Omeros Corp | -34,825,000.0 | -34,943,000.0 | -23,535,000.0 |
QTRX Quanterix Corp | -5,984,000.0 | -8,200,000.0 | -26,882,000.0 |
QDEL QuidelOrtho Corp | 80,400,000.0 | 31,800,000.0 | -30,400,000.0 |
NEOG Neogen Corp | -30,206,000.0 | -62,327,000.0 | -44,328,000.0 |
BIO Bio Rad Laboratories Inc | 81,047,000.0 | 38,802,000.0 | -53,946,000.0 |
TGTX TG Therapeutics Inc | -13,210,000.0 | -13,210,000.0 | -57,966,000.0 |
BSX Boston Scientific Corp | 957,000,000.0 | 690,000,000.0 | -77,000,000.0 |
EYE National Vision Holdings Inc | 19,761,000.0 | -13,048,000.0 | -116,125,000.0 |
載入數據中...
最新要聞
和醫療產品相關的產業概念股
醫療產品概念股相關指標排名
醫療產品每月營收
醫療產品每股盈餘
醫療產品每股淨值
醫療產品損益表
醫療產品總資產
醫療產品負債和股東權益
醫療產品現金流量表
醫療產品利潤比率
醫療產品營業費用率拆解
醫療產品杜邦分析
醫療產品ROE / ROA
醫療產品經營週轉能力
醫療產品營運週轉天數
醫療產品現金股利發放率
醫療產品財務結構比率
醫療產品流速動比率
醫療產品利息保障倍數
醫療產品現金流量分析
醫療產品營業現金流對淨利比
醫療產品盈餘再投資比率
醫療產品月營收成長率
醫療產品營收成長率
醫療產品毛利成長率
醫療產品營業利益成長率
醫療產品稅後淨利成長率
醫療產品每股盈餘成長率
醫療產品本益比評價
醫療產品股價淨值比評價
醫療產品現金股利殖利率
醫療產品平均現金股息殖利率
醫療產品董監持股比例
醫療產品董監持股質押比例